Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

NK cells inhibit anti‐Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model

NK cells inhibit anti‐Mycobacterium bovis BCG T cell responses and aggravate pulmonary... Tuberculosis remains a threat to public health. The major problem for curing this disease is latent infection, of which the underlying mechanisms are still not fully understood. Previous studies indicate that natural killer (NK) cells do not play a role in inhibiting the growth of Mycobacterium tuberculosis in the lung, and recent studies have revealed that NK cells regulate the adaptive immunity during mycobacterial infection. By using a mouse model of direct lung infection with Mycobacterium bovis bacillus Calmette‐Guerin (BCG), we found that the presence of NK cells postponed the priming and activation of T cells after BCG infection. In addition, depletion of NK cells before infection alleviated pulmonary pathology. Further studies showed that NK cells lysed BCG‐infected macrophages in an NKG2D dependent manner. Thus, NK cells did not play a direct role in control BCG, but aggravated the pulmonary inflammation and impaired anti‐BCG T cell immunity, likely through killing BCG‐infected macrophages. Our results may have important implications for the design of immune therapy to treat tuberculosis. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cellular Microbiology Wiley

NK cells inhibit anti‐Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model

Download PDF
12 pages

Loading next page...
 
/lp/wiley/nk-cells-inhibit-anti-mycobacterium-bovis-bcg-t-cell-responses-and-klu9M74Kc5
Publisher
Wiley
Copyright
"© 2018 John Wiley & Sons Ltd"
ISSN
1462-5814
eISSN
1462-5822
DOI
10.1111/cmi.12833
Publisher site
See Article on Publisher Site

Abstract

Tuberculosis remains a threat to public health. The major problem for curing this disease is latent infection, of which the underlying mechanisms are still not fully understood. Previous studies indicate that natural killer (NK) cells do not play a role in inhibiting the growth of Mycobacterium tuberculosis in the lung, and recent studies have revealed that NK cells regulate the adaptive immunity during mycobacterial infection. By using a mouse model of direct lung infection with Mycobacterium bovis bacillus Calmette‐Guerin (BCG), we found that the presence of NK cells postponed the priming and activation of T cells after BCG infection. In addition, depletion of NK cells before infection alleviated pulmonary pathology. Further studies showed that NK cells lysed BCG‐infected macrophages in an NKG2D dependent manner. Thus, NK cells did not play a direct role in control BCG, but aggravated the pulmonary inflammation and impaired anti‐BCG T cell immunity, likely through killing BCG‐infected macrophages. Our results may have important implications for the design of immune therapy to treat tuberculosis.

Journal

Cellular Microbiology – Wiley

Published: Jul 1, 2018

Keywords: ; ; ; ;

References

  • NK cells are essential for effective BCG immunotherapy
    Brandau, S.; Riemensberger, J.; Jacobsen, M.; Kemp, D.; Zhao, W.; Zhao, X.; Böhle, A.
  • ESAT‐6 proteins: Protective antigens and virulence factors?
    Brodin, P.; Rosenkrands, I.; Andersen, P.; Cole, S. T.; Brosch, R.
  • Cutting edge: Murine UL16‐binding protein‐like transcript 1: A newly described transcript encoding a high‐affinity ligand for murine NKG2D
    Carayannopoulos, L. N.; Naidenko, O. V.; Fremont, D. H.; Yokoyama, W. M.
  • Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice
    Cerwenka, A.; Bakker, A. B. H.; McClanahan, T.; Wagner, J.; Wu, J.; Phillips, J. H.; Lanier, L. L.
  • NKG2D ligands: Unconventional MHC class I‐like molecules exploited by viruses and cancer
    Cerwenka, A.; Lanier, L. L.
  • Natural killer cells regulate diverse T cell responses
    Crome, S. Q.; Lang, P. A.; Lang, K. S.; Ohashi, P. S.
  • NK cells regulating T cell responses: Mechanisms and outcome
    Crouse, J.; Xu, H. C.; Lang, P. A.; Oxenius, A.
  • Natural killer cells in infection and inflammation of the lung
    Culley, F. J.
  • IL‐10 inhibits mature fibrotic granuloma formation during Mycobacterium tuberculosis infection
    Cyktor, J. C.; Carruthers, B.; Kominsky, R. A.; Beamer, G. L.; Stromberg, P.; Turner, J.
  • IL‐22 produced by human NK cells inhibits growth of Mycobacterium tuberculosis by enhancing phagolysosomal fusion
    Dhiman, R.; Indramohan, M.; Barnes, P. F.; Nayak, R. C.; Paidipally, P.; Rao, L. V. M.; Vankayalapati, R.
  • NK1.1+ cells and IL‐22 regulate vaccine‐induced protective immunity against challenge with Mycobacterium tuberculosis
    Dhiman, R.; Periasamy, S.; Barnes, P. F.; Jaiswal, A. G.; Paidipally, P.; Barnes, A. B.; Vankayalapati, R.
  • A role for NKG2D in NK cell‐mediated resistance to poxvirus disease
    Fang, M.; Lanier, L. L.; Sigal, L. J.
  • Lessons from experimental mycobacterium tuberculosis infections
    Flynn, J. L.
  • An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
    Flynn, J. L.; Chan, J.; Triebold, K. J.; Dalton, D. K.; Stewart, T. A.; Bloom, B. R.
  • Comparable studies of immunostimulating activities in vitro among Mycobacterium bovis bacillus Calmette‐Guerin (BCG) substrains
    Hayashi, D.; Takii, T.; Fujiwara, N.; Fujita, Y.; Yano, I.; Yamamoto, S.; Onozaki, K.
  • The role of the NKG2D immunoreceptor in immune cell activation and natural killing
    Jamieson, A. M.; Diefenbach, A.; McMahon, C. W.; Xiong, N.; Carlyle, J. R.; Raulet, D. H.
  • NK cells respond to pulmonary infection with Mycobacterium tuberculosis, but play a minimal role in protection
    Junqueira‐Kipnis, A. P.; Kipnis, A.; Jamieson, A.; Juarrero, M. G.; Diefenbach, A.; Raulet, D. H.; Orme, I. M.
  • NK cell recognition
    Lanier, L. L.
  • NKG2D receptor and its ligands in host defense
    Lanier, L. L.
  • Laboratory maintenance of Mycobacterium tuberculosis
    Larsen, M. H.; Biermann, K.; Jacobs, W. R.
  • The acid‐fast stain: A specific and predictive test for mycobacterial disease
    Murray, P. R.; Elmore, C.; Krogstad, D. J.
  • A mouse model for slowly progressive primary tuberculosis
    Mustafa, T.; Phyu, S.; Nilsen, R.; Jonsson, R.; Bjune, G.
  • The immune response in tuberculosis
    O'Garra, A.; Redford, P. S.; McNab, F. W.; Bloom, C. I.; Wilkinson, R. J.; Berry, M. P. R.
  • Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell‐deficient recipients
    Orme, I. M.; Collins, F. M.
  • Natural killer cell cytokine response to M. bovis BCG is associated with inhibited proliferation, increased apoptosis and ultimate depletion of NKp44+ CD56 bright cells
    Portevin, D.; Young, D.
  • Roles of the NKG2D immunoreceptor and its ligands
    Raulet, D. H.
  • NK cells lyse T regulatory cells that expand in response to an intracellular pathogen
    Roy, S.; Barnes, P. F.; Garg, A.; Wu, S.; Cosman, D.; Vankayalapati, R.
  • Foamy macrophages and the progression of the human tuberculosis granuloma
    Russell, D. G.; Cardona, P. J.; Kim, M. J.; Allain, S.; Altare, F.
  • Cutting edge: CD8+ T cell priming in the absence of NK cells leads to enhanced memory responses
    Soderquest, K.; Walzer, T.; Zafirova, B.; Klavinskis, L. S.; Polic, B.; Vivier, E.; Martin‐Fontecha, A.
  • NK cell functions restrain T cell responses during viral infections
    Su, H. C.; Nguyen, K. B.; Salazar‐Mather, T. P.; Ruzek, M. C.; Dalod, M. Y.; Biron, C. A.
  • Direct visual instillation as a method for efficient delivery of fluid into the distal airspaces of anesthetized mice
    Su, X.; Looney, M.; Robriquet, L.; Fang, X.; Matthay, M. A.
  • Bone marrow‐derived dendritic cells can process bacteria for MHC‐I and MHC‐II presentation to T cells
    Svensson, M.; Stockinger, B.; Wick, M. J.
  • Natural killer cells in innate defense against infective pathogens
    Wang, D.; Ma, Y.; Wang, J.; Liu, X.; Fang, M.
  • Swift and strong NK cell responses protect 129 mice against high‐dose influenza virus infection
    Zhou, K.; Wang, J.; Li, A.; Zhao, W.; Wang, D.; Zhang, W.; Fang, M.
  • NK cell regulation of T cell‐mediated responses
    Zingoni, A.; Sornasse, T.; Cocks, B. G.; Tanaka, Y.; Santoni, A.; Lanier, L. L.